编号/登记号：
NCT03451526
注册时间：
2018-03-01
研究开始时间：
2017-12-01
研究结束时间：
2017-12-01
项目类型：
clinicaltrials临床试验
本院角色：
参与单位
多中心研究：
国际多中心
招募状态：
Completed
研究疾病/适应症：
Non-small Cell Lung Cancer
研究类型：
Observational
研究单位：
[1]Tang-Du Hospital
[2]Tongji Hospital Affiliated to Huazhong Technology Hospital Wuhan, Hubei, China, 430030
[3]China-Japan Friendship Hospital Beijing, Beijing, China, 100029
[4]China PLA General Hospital Beijing, Beijing, China, 100853
[5]Henan cancer hospital Zhengzhou, Henan, China, 450008
[6]Jiangsu cancer hospital Nanjing, Jiangsu, China, 210009
[7]Xi'an Tangdu Hospital Xi'an, Shaanxi, China, 710000
[8]Shanghai Chest Hospital Shanghai, Shanghai, China, 200003
[9]Huaxi Hospital Affiliated to Sichuan University Chengdu, Sichuan, China, 610041
[10]Tianjin Chest Hospital Tianjin, Tianjin, China, 300051
[11]First Hospital Affiliated to Zhejiang University Hangzhou, Zhejiang, China, 310003
关键词：
Chinese
real-world evidences
NSCLC
surgeries
研究目的：
The trial was designed to compare the effectiveness of radical resections of lung cancer plus adjuvant chemotherapies and perioperative chemotherapies in the patients with N2 non-small cell lung cancer
